Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a UK-based pioneer
in low cost, ultra-low power wireless technology, has started the pilot
of its digital vital signs monitor, SensiumVitals, at St. John's
Health Center, Santa Monica, California; a major US hospital.
The SensiumVitals monitor is a disposable, ultra-thin plaster
which continuously monitors the patient's heart rate, respiratory rate
and temperature whilst in hospital. The monitor significantly increased
patient surveillance compared to current practice, which involves manual
measurement of vital signs every six to eight hours.
SensiumVitals is intended for use in general hospital wards which
account for the vast majority of hospital beds, as opposed to
traditional monitoring devices which can be bulky, wired products and
may be restricted to intensive care units. The device, which also has an
alert capability, enables patients to be fully mobile whilst being
Any deterioration in condition can be detected by the SensiumVitals monitor
and dealt with immediately, thereby reducing the number of patients
admitted or readmitted to intensive care and the overall hospital spend.
In the US alone, wireless vital signs monitoring devices are forecast to
reduce healthcare costs by around $200 billion over the next 25 years
(Center for Technology and Aging Report, May 2010).
The pilot is being carried out at St. John's Health Centre in Santa
Monica, California, by Toumaz US, the Group's US joint venture with Dr
Patrick Soon-Shiong's company NantWorks.
Anthony Sethill, CEO of Toumaz, commented:
"This pilot is a major milestone for the Group as we start to
commercialise our low cost, ultra-low power wireless technologies for
use in the medical markets.
"This disruptive wireless monitoring technology is the world's
first FDA cleared and fully disposable vital signs monitoring solution
for general use in hospitals. SensiumVitals represents a
breakthrough in how patient care is delivered, setting a new, cost
effective standard for hospitals and also benefitting patients' recovery.
"Early feedback from patients and hospital staff at St John's has
been very positive with the device detecting deterioration in patients'
conditions instantaneously, enabling intervention much sooner than
Michael Trevino, CTO of NantHealth, a NantWorks company,
"At NantWorks, we believe continuous patient monitoring in the
hospital will one day be standard practice and this will be enabled by
foundational technology like SensiumVitals, delivered by Toumaz US.
Continuously streamed patient data automatically flowing into hospital
information systems will drive the right care at the right time and in
the right place."
The SensiumVitals digital plaster is a fully disposable device,
with smart sensor interface and transceiver, aimed at the general wards
of hospitals. The device continuously monitors patients' vital signs
(heart-rate, respiration rate & temperature) and wirelessly communicates
this data to doctors and nurses via the hospital's IT system.
Currently, the majority of patients in hospital have measurements of
vital signs taken manually at six to eight hour intervals. This
relatively infrequent monitoring means that deterioration in patient
conditions may go unnoticed, leading to further treatment or
re-admittance to intensive care units.
The SensiumVitals monitor is a disposable ultra-thin plaster that
is attached to patients under their clothing. The device enables the
patient to be completely ambulatory and still be monitored.
Hospital staff can set up alerts that can be sent to pagers/handheld
devices to warn them of patient deterioration. This enables caregivers
to prioritise patients based on their condition. SensiumVitals
has a battery life of five days, covering the average length of a
general ward stay in the hospital. At the end of a patient's stay the
entire device can be disposed of.
Key benefits include:
Enables early detection of deterioration - patients at risk can be
treated sooner / improves patient safety
Lightweight unobtrusive wireless plaster is comfortable to wear and
enables patients to be ambulatory - improves patient recovery
Plasters can be disposed of after use - no risk of infection
transmission from one patient to another
Integrates well with existing clinical workflows and will be useful
for generating patient early warning scores
About Toumaz - (www.toumazltd.com)
Toumaz is a pioneer in low cost, ultra-low power wireless technologies
for a wide range of markets including medical monitoring and internet
connected consumer devices. The recent acquisition of Frontier Silicon
brings operational scale and expertise together with a leadership
position in digital and networked audio markets.
The Group combines its strong IP and technology base with the commercial
scale of Frontier to exploit two key wireless technology sectors:
Professional healthcare solutions
Consumer semiconductors in digital audio and sport & health markets
Toumaz's ultra-low power sensor platform, Sensium?, targets the
professional healthcare market and is a leader in real-time wireless
monitoring of the body's vital signs with the potential to transform
medical monitoring and reduce the cost of healthcare. SensiumVitals is
the Group's first product in this field. For healthcare professionals,
this creates new opportunities for pro-active monitoring and improved
quality of care. For patients, it delivers new opportunities for
Toumaz plans to transfer its Sensium? technology to the consumer sports
and health market, where its advanced measurement algorithms and low
energy solutions give it a competitive advantage.
Toumaz is also using its expertise to design devices for wireless
connectivity and internet-connected The acquisition of Frontier Silicon
has enhanced the Group's technology portfolio in Network Audio and
elevates Toumaz to a market leadership position in this and the digital
radio markets. The Group now supplies multimedia/FM/DAB chips and
modules to all major audio brands.
Toumaz is an AIM listed company (AIM: TMZ) with development centres in
Oxford and Cambridge in the UK and in Hong Kong and in Shenzhen in the
People's Republic of China.
+44 (0)20 7457 2020